Trial
NCT04395950
Effects of ACC Inhibitor on Lipid and Lipoprotein Metabolism
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
Pfizer
Condition
NASH (Nonalcoholic Steatohepatitis)
Intervention
PF-05221304
Why stopped
Poor enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-25